Find participating medical centers and current study status in each of them
Find participating medical centers
-
Home
-
Clinical Study Finder
- Clinical Study Details
A Study of Atezolizumab Plus Cobimetinib and Vemurafenib Versus Placebo Plus Cobimetinib and Vemurafenib in Previously Untreated BRAFv600 Mutation-Positive Patients With Metastatic or Unresectable Locally Advanced Melanoma
Cancer Skin Cancer Malignant Melanoma Melanoma
Study results
LPS CO39262 Final Results January 2025 English
(PDF, 0.3 MB)
LPS CO39262 Final Results January 2025 Brazil Portuguese
(PDF, 0.4 MB)
LPS CO39262 Final Results January 2025 Canada French
(PDF, 1.0 MB)
LPS CO39262 Final Results January 2025 Austria German
(PDF, 0.4 MB)
LPS CO39262 Final Results January 2025 Belgium Dutch
(PDF, 0.5 MB)
LPS CO39262 Final Results January 2025 Germany German
(PDF, 0.4 MB)
LPS CO39262 Final Results January 2025 Greek
(PDF, 0.8 MB)
LPS CO39262 Final Results January 2025 Hebrew
(PDF, 0.5 MB)
LPS CO39262 Final Results January 2025 Hungarian
(PDF, 0.5 MB)
LPS CO39262 Final Results January 2025 Korean
(PDF, 0.7 MB)
LPS CO39262 Final Results January 2025 Netherlands Dutch
(PDF, 0.5 MB)
LPS CO39262 Final Results January 2025 Polish
(PDF, 0.5 MB)
LPS CO39262 Final Results January 2025 Portugal Portuguese
(PDF, 0.5 MB)
LPS CO39262 Final Results January 2025 Russian
(PDF, 0.5 MB)
LPS CO39262 Final Results January 2025 Italian
(PDF, 0.4 MB)
LPS CO39262 Final Results January 2025 Spanish
(PDF, 0.4 MB)
Explore related studies
For the latest version of this information please go to www.forpatients.roche.com